title

Minneapolis Heart Institute Foundation Cardiology Grand Rounds

Minneapolis Heart Institute Foundation

0
Followers
0
Plays
Minneapolis Heart Institute Foundation Cardiology Grand Rounds
Minneapolis Heart Institute Foundation Cardiology Grand Rounds

Minneapolis Heart Institute Foundation Cardiology Grand Rounds

Minneapolis Heart Institute Foundation

0
Followers
0
Plays
OVERVIEWEPISODESYOU MAY ALSO LIKE

Details

About Us

Stay up-to-date on the latest developments in cardiology.

Latest Episodes

Riata ICD Leads: Is there a problem or just a cosmetic issue?

Dr. Raed H. Abdelhadi, Cardiac Electrophysiologist at the Minneapolis Heart Institute at Abbott Northwestern Hospital, reviews the background for the Riata ICD recall and the available data on the Riata ICD lead, explains the preliminary results for the Riata Multicenter Study, discusses the challenges regarding screening and management and summarizes the Riata Summit.

-1 s2012 JAN 30
Comments
Riata ICD Leads: Is there a problem or just a cosmetic issue?

Decongestive Strategies in Acute Heart Failure

Dr. Steven R. Goldsmith, Professor of Medicine at the University of Minnesota, Director of the Heart Failure Program at Hennepin County Medical Center, and Director of the Minnesota Heart Failure Consortium, explains the importance of congestion as a contributor to the pathophysiology of acute heart failure, describes the limits of current decongestive strategies and the promise of newer modalities and discusses emerging insights concerning the relationship between congestion and the cardiorenal syndrom in acute heart failure.

-1 s2012 JAN 16
Comments
Decongestive Strategies in Acute Heart Failure

Atrial Fibrillation: New Agents for Stroke Prevention

Dr. R. Jeffrey Westcott, Medical Director at the Cardiac Cath Lab at the Swedish Heart and Vascular Institute, discusses the pharmacology of the new oral direct thrombin and Xa inhibitors, evaluates what patients are more likely to experience bleeding complications and discusses the advantages of these agents versus warfarin in treating patients with non-valvular atrial fibrillation.

-1 s2011 DEC 19
Comments
Atrial Fibrillation: New Agents for Stroke Prevention

TCT/AHA Highlights: Platelets and Stem Cells

Dr. Timothy Henry, Director of Research at the Minneapolis Heart Institute Foundation, and Dr. Jay Traverse, Senior Consulting Cardiologist at the Minneapolis Heart Institute at Abbott Northwestern Hospital, review the results of the LateTIME, SCIPIO and CADUCEUS trials.

-1 s2011 NOV 28
Comments
TCT/AHA Highlights: Platelets and Stem Cells

Update in Preventive Cardiology 2011

Dr. Thomas Knickelbine, Director of Preventive Cardiology at the Minneapolis Heart Institute at Abbott Northwestern Hospital discusses US population risk factors, explains how to approach patients with statin intolerance, describes the current approaches to treatment of non-HDL cholesterol and Metabolic Syndrome and outlines MHI prevention goals and future vision.

-1 s2011 NOV 21
Comments
Update in Preventive Cardiology 2011

AHA Abstract Presentations

Acute Aortic Intramural Hematoma: an analysis from the International Registry of Acute Aortic Dissection - Presented by Dr. Kevin M. Harris Circadian Dependence of Infarct Size and Left-Ventricular Function Following ST-Elevation Myocardial Infarction - Presented by Dr. Ronald Reiter Cardiogenic Shock in Cardiac Arrest No Longer a Contraindication for Therapeutic Hypothermia - Presented by Fourth-Year Medical Student, Kalie Y. Kebed Prevalence of Premature Coronary Heart Disease and Female Gender in Patients Presenting with ST-Elevation Myocardial Infarction - Presented by Dr. Michael D. Miedema

-1 s2011 OCT 31
Comments
AHA Abstract Presentations

Critical Limb Ischemia: Is there a role for drug eluting stents in the periphery?

Dr. Steve Levin, Vascular Fellow at the University of Minnesota, defines critical limb ischemia, identifies the evolving role of drug eluting stents in the treatment of peripheral arterial disease and compares how drug eluting stents have performed relative to balloon angioplasty and bare metal stenting in patients suffering from critical limb ischemia.

-1 s2011 OCT 24
Comments
Critical Limb Ischemia: Is there a role for drug eluting stents in the periphery?

Repairing Valves: Why and Why Not?

Dr. Benjamin Sun, Chair of Cardiac, Thoracic and Transplant Surgery at the Minneapolis Heart Institute at Abbott Northwestern Hospital, identifies which valves can be repaired, explains why we don't repair valves more frequently and describes when valve replacement is still preferred.

-1 s2011 OCT 17
Comments
Repairing Valves: Why and Why Not?

Cardiac Resynchronization Therapy: Developing a Center of Excellence

Dr. Alan J. Bank,Medical Director of Research at United Heart and Vascular Clinic, andAssociate Professor of Cardiology at the University of Minnesota, describes the components of a CRT Center of Excellence, explains the mechanisms of action of CRT, discusses the importance of mechanical dyssynchrony in heart failure, and describes the effects of CRT in patients with NYHA Class II heart failure.

-1 s2011 OCT 3
Comments
Cardiac Resynchronization Therapy: Developing a Center of Excellence

A Serious Complication of a Common Vascular Practice

Dr. Nedaa Skeik,Vascular Medicine Consultant at the Minneapolis Heart Institute atAbbott Northwestern Hospital, explains different treatment modalities for deep vein thrombosis (DVT), describes the history of inferior vena cava (IVC) filters, lists indications and complications(common and rare) of IVC filters, and explains identification and management of arterial pseudoaneurysm as a rare complication of IVC filters.

-1 s2011 SEP 26
Comments
A Serious Complication of a Common Vascular Practice

Latest Episodes

Riata ICD Leads: Is there a problem or just a cosmetic issue?

Dr. Raed H. Abdelhadi, Cardiac Electrophysiologist at the Minneapolis Heart Institute at Abbott Northwestern Hospital, reviews the background for the Riata ICD recall and the available data on the Riata ICD lead, explains the preliminary results for the Riata Multicenter Study, discusses the challenges regarding screening and management and summarizes the Riata Summit.

-1 s2012 JAN 30
Comments
Riata ICD Leads: Is there a problem or just a cosmetic issue?

Decongestive Strategies in Acute Heart Failure

Dr. Steven R. Goldsmith, Professor of Medicine at the University of Minnesota, Director of the Heart Failure Program at Hennepin County Medical Center, and Director of the Minnesota Heart Failure Consortium, explains the importance of congestion as a contributor to the pathophysiology of acute heart failure, describes the limits of current decongestive strategies and the promise of newer modalities and discusses emerging insights concerning the relationship between congestion and the cardiorenal syndrom in acute heart failure.

-1 s2012 JAN 16
Comments
Decongestive Strategies in Acute Heart Failure

Atrial Fibrillation: New Agents for Stroke Prevention

Dr. R. Jeffrey Westcott, Medical Director at the Cardiac Cath Lab at the Swedish Heart and Vascular Institute, discusses the pharmacology of the new oral direct thrombin and Xa inhibitors, evaluates what patients are more likely to experience bleeding complications and discusses the advantages of these agents versus warfarin in treating patients with non-valvular atrial fibrillation.

-1 s2011 DEC 19
Comments
Atrial Fibrillation: New Agents for Stroke Prevention

TCT/AHA Highlights: Platelets and Stem Cells

Dr. Timothy Henry, Director of Research at the Minneapolis Heart Institute Foundation, and Dr. Jay Traverse, Senior Consulting Cardiologist at the Minneapolis Heart Institute at Abbott Northwestern Hospital, review the results of the LateTIME, SCIPIO and CADUCEUS trials.

-1 s2011 NOV 28
Comments
TCT/AHA Highlights: Platelets and Stem Cells

Update in Preventive Cardiology 2011

Dr. Thomas Knickelbine, Director of Preventive Cardiology at the Minneapolis Heart Institute at Abbott Northwestern Hospital discusses US population risk factors, explains how to approach patients with statin intolerance, describes the current approaches to treatment of non-HDL cholesterol and Metabolic Syndrome and outlines MHI prevention goals and future vision.

-1 s2011 NOV 21
Comments
Update in Preventive Cardiology 2011

AHA Abstract Presentations

Acute Aortic Intramural Hematoma: an analysis from the International Registry of Acute Aortic Dissection - Presented by Dr. Kevin M. Harris Circadian Dependence of Infarct Size and Left-Ventricular Function Following ST-Elevation Myocardial Infarction - Presented by Dr. Ronald Reiter Cardiogenic Shock in Cardiac Arrest No Longer a Contraindication for Therapeutic Hypothermia - Presented by Fourth-Year Medical Student, Kalie Y. Kebed Prevalence of Premature Coronary Heart Disease and Female Gender in Patients Presenting with ST-Elevation Myocardial Infarction - Presented by Dr. Michael D. Miedema

-1 s2011 OCT 31
Comments
AHA Abstract Presentations

Critical Limb Ischemia: Is there a role for drug eluting stents in the periphery?

Dr. Steve Levin, Vascular Fellow at the University of Minnesota, defines critical limb ischemia, identifies the evolving role of drug eluting stents in the treatment of peripheral arterial disease and compares how drug eluting stents have performed relative to balloon angioplasty and bare metal stenting in patients suffering from critical limb ischemia.

-1 s2011 OCT 24
Comments
Critical Limb Ischemia: Is there a role for drug eluting stents in the periphery?

Repairing Valves: Why and Why Not?

Dr. Benjamin Sun, Chair of Cardiac, Thoracic and Transplant Surgery at the Minneapolis Heart Institute at Abbott Northwestern Hospital, identifies which valves can be repaired, explains why we don't repair valves more frequently and describes when valve replacement is still preferred.

-1 s2011 OCT 17
Comments
Repairing Valves: Why and Why Not?

Cardiac Resynchronization Therapy: Developing a Center of Excellence

Dr. Alan J. Bank,Medical Director of Research at United Heart and Vascular Clinic, andAssociate Professor of Cardiology at the University of Minnesota, describes the components of a CRT Center of Excellence, explains the mechanisms of action of CRT, discusses the importance of mechanical dyssynchrony in heart failure, and describes the effects of CRT in patients with NYHA Class II heart failure.

-1 s2011 OCT 3
Comments
Cardiac Resynchronization Therapy: Developing a Center of Excellence

A Serious Complication of a Common Vascular Practice

Dr. Nedaa Skeik,Vascular Medicine Consultant at the Minneapolis Heart Institute atAbbott Northwestern Hospital, explains different treatment modalities for deep vein thrombosis (DVT), describes the history of inferior vena cava (IVC) filters, lists indications and complications(common and rare) of IVC filters, and explains identification and management of arterial pseudoaneurysm as a rare complication of IVC filters.

-1 s2011 SEP 26
Comments
A Serious Complication of a Common Vascular Practice
hmly
himalayaプレミアムへようこそ聴き放題のオーディオブックをお楽しみください。